Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
SEC Accession No. 0001731122-24-001584
Filing Date
2024-10-10
Accepted
2024-10-10 17:07:21
Documents
16
Period of Report
2022-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-K/A e6020_10-ka.htm 10-K/A 1219911
2 EXHIBIT 23.1 e6020_ex23-1.htm EX-23.1 3580
3 EXHIBIT 31.1 e6020_ex31-1.htm EX-31.1 13838
4 EXHIBIT 31.2 e6020_ex31-2.htm EX-31.2 13811
5 EXHIBIT 32.1 e6020_ex32-1.htm EX-32.1 5324
6 EXHIBIT 32.2 e6020_ex32-2.htm EX-32.2 5017
7 GRAPHIC img_001.jpg GRAPHIC 66427
8 GRAPHIC img_002.jpg GRAPHIC 64570
9 GRAPHIC img_003.jpg GRAPHIC 142007
10 GRAPHIC img_004.jpg GRAPHIC 61082
11 GRAPHIC img_005.jpg GRAPHIC 34857
12 GRAPHIC img_006.jpg GRAPHIC 55635
13 GRAPHIC img_007.jpg GRAPHIC 156145
14 GRAPHIC img_008.jpg GRAPHIC 118204
15 GRAPHIC img_009.jpg GRAPHIC 66641
16 GRAPHIC image_010.jpg GRAPHIC 6802
  Complete submission text file 0001731122-24-001584.txt   2327766
Mailing Address 1055 WESTLAKES DRIVE, SUITE 300 BERWYN PA 19312
Business Address 1055 WESTLAKES DRIVE, SUITE 300 BERWYN PA 19312 610-727-4597
Virpax Pharmaceuticals, Inc. (Filer) CIK: 0001708331 (see all company filings)

EIN.: 821510982 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K/A | Act: 34 | File No.: 001-40064 | Film No.: 241365805
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)